United Therapeutics Files New Drug Application For Tyvaso DPI- Quick Fats

MannKind Corporation (MNKD) and United Therapeutics (UTHR) today said United Therapeutics has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for its Tyvaso DPI.

Tyvaso DPI is a dry powder formulation of Tyvaso, delivered via a portable inhaler, for the treatments of pulmonary arterial hypertension (PAH), and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Tyvaso (treprostinil) inhalation solution, developed by United Therapeutics was approved in 2009 for the treatment of Pulmonary Arterial Hypertension.

Tyvaso DPI incorporates the same dry powder formulation technology and Dreamboat inhalation device technology used in MannKind's Afrezza Inhalation Powder, which was approved in 2014.

United Therapeutics has applied a priority review voucher to its NDA for Tyvaso DPI. A decision is expected by December 2021.

In 2018, MannKind and United Therapeutics had entered into a worldwide licensing and collaboration agreement for the development and commercialization of Tyvaso DPI.

"If approved by the FDA, Tyvaso DPI is expected to provide a major advancement in the delivery of inhaled treprostinil for PAH and PH-ILD patients," said Michael Castagna, CEO of MannKind Corporation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Oilfield services company Schlumberger Ltd. reported Friday a profit for the fourth quarter that surged 61 percent from last year, reflecting 13 percent higher revenues amid growth across all segments and regions. Both adjusted earnings per share and quarterly revenues topped analysts' estimates. Twitter Inc. has launched a new feature to allow some users of its Blue subscriber service to keep non-fungible tokens or NFTs as their profile pictures. Twitter Blue is now available in the US, Canada, Australia, and New Zealand. NFT is a crypto token, which is non-fungible, meaning that it can neither be transferred like money nor replaced with something else. Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23.
Follow RTT